Market Overview:
The global norepinephrine bitartrate injection market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing incidence of cardiovascular diseases and rising demand for better treatment options. By type, the 2mg segment is expected to account for a major share of the market in 2018, owing to its high usage in shock hypotensive applications. However, the 4mg segment is projected to grow at a higher CAGR during the forecast period due to its growing demand in AMI hypotension applications. By application, shock hypotensive held a dominant share of more than 60% of the global norepinephrine bitartrate injection market in 2017 and is anticipated to maintain its dominance throughout the forecast period.
Product Definition:
Norepinephrine Bitartrate Injection is a drug used to increase heart rate and blood pressure. It is a type of catecholamine, which are hormones that are released by the body in response to stress. Norepinephrine Bitartrate Injection is most often used to treat low blood pressure and heart problems caused by shock.
2mg:
2mg is a prescription drug used to treat symptoms of low blood pressure, such as dizziness and fainting. It is also used to treat conditions caused by excessive sweating, including hyperthyroidism and adrenal insufficiency. 2mg norepinephrine bitartrate injection is a form of vasopressors that works by reducing the amount of fluid in the brain (hydrocephalus).
It helps raise blood pressure when it falls too low.
4mg:
4mg is a prescription drug used to treat the symptoms of Enhydro Epinephrine (EH) or what is commonly known as "High Blood Pressure". It works by increasing the amount of fluid in the blood vessels, which allows it to rise above 140/90 mm Hg and below160/100 mmHg.
Application Insights:
The shock hypotensive segment held the largest share of over 50.0% in 2017. The increasing prevalence of cardiovascular diseases and rising number of deaths due to cardiac arrest are among the major factors driving the demand for norepinephrine bitartrate injection in this segment. Moreover, favorable reimbursement policies coupled with growing awareness about CVDs will further boost market growth during the forecast period.
AMI hypotension is anticipated to be one of the fastest-growing segments owing to increased incidence rates and mortality rate associated with this condition which eventually leads to permanent brain damage or death in severe cases. Thus, increasing government initiatives towards reducing these statistics is expected to increase product demand during forecast years, thereby driving global norepinephrine bitartrate injection market growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high demand forbitartrate-injectable products. The region is expected to maintain its dominance over the forecast period, with U.S., being the largest contributor, as it has been observed that more than 80% of bitartrate sales are from formulations used in injectables.
Asia Pacific is anticipated to be one of fastest growing regions during the forecast period due to increasing healthcare spending by governments and rising awareness about bitartrate-based insulin delivery systems among patients suffering from diabetes. Moreover, increasing prevalence ratesof cardiovascular diseasesare also expectedto drivethe regional growth over next eight years.
Growth Factors:
- Increasing demand for norepinephrine bitartrate injection in the treatment of hypotension and sepsis
- Rising geriatric population susceptible to various health conditions requiring norepinephrine bitartrate injection therapy
- Growing number of hospitals and clinics offering norepinephrine bitartrate injection services
- Technological advancements in the manufacturing of norepinephrine bitartrate injection products
- increasing awareness about the benefits of using norepinephrine bitartrate injections among physicians and patients
Scope Of The Report
Report Attributes
Report Details
Report Title
Norepinephrine Bitartrate Injection Market Research Report
By Type
2mg, 4mg, Other
By Application
Shock Hypotensive, AMI Hypotension, Other
By Companies
Pfizer, Novartis, Teva, Amneal Biosciences, Baxter, Mylan, Hikma Pharmaceuticals, Shanghai Harvest, Grand Pharmaceutical, King York, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Norepinephrine Bitartrate Injection Market Report Segments:
The global Norepinephrine Bitartrate Injection market is segmented on the basis of:
Types
2mg, 4mg, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Shock Hypotensive, AMI Hypotension, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis
- Teva
- Amneal Biosciences
- Baxter
- Mylan
- Hikma Pharmaceuticals
- Shanghai Harvest
- Grand Pharmaceutical
- King York
- Pfizer
Highlights of The Norepinephrine Bitartrate Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2mg
- 4mg
- Other
- By Application:
- Shock Hypotensive
- AMI Hypotension
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Norepinephrine Bitartrate Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Norepinephrine bitartrate injection is a medication used to treat hypertension. It works by increasing the amount of blood that flows through your arteries.
Some of the key players operating in the norepinephrine bitartrate injection market are Pfizer, Novartis, Teva, Amneal Biosciences, Baxter, Mylan, Hikma Pharmaceuticals, Shanghai Harvest, Grand Pharmaceutical, King York, Pfizer.
The norepinephrine bitartrate injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Norepinephrine Bitartrate Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Norepinephrine Bitartrate Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Norepinephrine Bitartrate Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Norepinephrine Bitartrate Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Norepinephrine Bitartrate Injection Market Size & Forecast, 2018-2028
4.5.1 Norepinephrine Bitartrate Injection Market Size and Y-o-Y Growth
4.5.2 Norepinephrine Bitartrate Injection Market Absolute $ Opportunity
Chapter 5 Global Norepinephrine Bitartrate Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Norepinephrine Bitartrate Injection Market Size Forecast by Type
5.2.1 2mg
5.2.2 4mg
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Norepinephrine Bitartrate Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Norepinephrine Bitartrate Injection Market Size Forecast by Applications
6.2.1 Shock Hypotensive
6.2.2 AMI Hypotension
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Norepinephrine Bitartrate Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Norepinephrine Bitartrate Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Norepinephrine Bitartrate Injection Analysis and Forecast
9.1 Introduction
9.2 North America Norepinephrine Bitartrate Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Norepinephrine Bitartrate Injection Market Size Forecast by Type
9.6.1 2mg
9.6.2 4mg
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Norepinephrine Bitartrate Injection Market Size Forecast by Applications
9.10.1 Shock Hypotensive
9.10.2 AMI Hypotension
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Norepinephrine Bitartrate Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Norepinephrine Bitartrate Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Norepinephrine Bitartrate Injection Market Size Forecast by Type
10.6.1 2mg
10.6.2 4mg
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Norepinephrine Bitartrate Injection Market Size Forecast by Applications
10.10.1 Shock Hypotensive
10.10.2 AMI Hypotension
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Norepinephrine Bitartrate Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Norepinephrine Bitartrate Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Norepinephrine Bitartrate Injection Market Size Forecast by Type
11.6.1 2mg
11.6.2 4mg
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Norepinephrine Bitartrate Injection Market Size Forecast by Applications
11.10.1 Shock Hypotensive
11.10.2 AMI Hypotension
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Norepinephrine Bitartrate Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Norepinephrine Bitartrate Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Norepinephrine Bitartrate Injection Market Size Forecast by Type
12.6.1 2mg
12.6.2 4mg
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Norepinephrine Bitartrate Injection Market Size Forecast by Applications
12.10.1 Shock Hypotensive
12.10.2 AMI Hypotension
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Norepinephrine Bitartrate Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Norepinephrine Bitartrate Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Norepinephrine Bitartrate Injection Market Size Forecast by Type
13.6.1 2mg
13.6.2 4mg
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Norepinephrine Bitartrate Injection Market Size Forecast by Applications
13.10.1 Shock Hypotensive
13.10.2 AMI Hypotension
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Norepinephrine Bitartrate Injection Market: Competitive Dashboard
14.2 Global Norepinephrine Bitartrate Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Novartis
14.3.3 Teva
14.3.4 Amneal Biosciences
14.3.5 Baxter
14.3.6 Mylan
14.3.7 Hikma Pharmaceuticals
14.3.8 Shanghai Harvest
14.3.9 Grand Pharmaceutical
14.3.10 King York
14.3.11 Pfizer
